This is in line with recently published data showing that the α-SMA+ area significantly increased in patients with nonalcoholic fatty liver disease and advanced fibrosis (F3) or cirrhosis (F4).25 The gene discussed is ACTA1; the disease is metabolic dysfunction-associated steatotic liver disease.